Relay Therapeutics, Inc. - stock earnings
RLAY Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | -0.62 / -0.72 | - | 10.0 million / 89250 | - |
| Aug. 6, 2024 BeforeMarket | - / - | - | - / 70000 | 300000 |
RLAY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -83.5 million USD | -1000 USD |
| 2023Q3 | -65.7 million USD | 25.2 million USD |
| 2023Q2 | -98.5 million USD | 119000 USD |
| 2023Q1 | -87.3 million USD | 226000 USD |
| 2022Q4 | -43.3 million USD | 253000 USD |
| 2022Q3 | -87.3 million USD | 344000 USD |
| 2022Q2 | -75.2 million USD | 365000 USD |
| 2022Q1 | -51.5 million USD | 419000 USD |
| 2021Q4 | -67.5 million USD | 567000 USD |
| 2021Q3 | -60.8 million USD | 666000 USD |
| 2021Q2 | -193.4 million USD | 844000 USD |
| 2021Q1 | -42.2 million USD | 952000 USD |
| 2020Q4 | 35.3 million USD | 82.7 million USD |
| 2020Q3 | -36.1 million USD | ? USD |
| 2020Q2 | -26.7 million USD | ? USD |
| 2020Q1 | -24.9 million USD | ? USD |
| 2019Q4 | -23.9 million USD | ? USD |
| 2019Q3 | -19.7 million USD | ? USD |
| 2019Q2 | -17.5 million USD | ? USD |
| 2019Q1 | -14.2 million USD | ? USD |
RLAY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -342.0 million USD | 25.5 million USD |
| 2022 | -254.3 million USD | 1.4 million USD |
| 2021 | -496.8 million USD | 3.0 million USD |
| 2020 | -49.0 million USD | 82.7 million USD |
| 2019 | -66.5 million USD | ? USD |
| 2018 | -48.8 million USD | ? USD |
RLAY
Price: $7.04
52 week price:
Earnings Per Share: -2.79 USD
P/E Ratio: -3.37
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.4 million
Market Capitalization: 934.5 million